Applied Precision Cancer Medicine in Neuro-Oncology

Brain tumours that are refractory to treatment have a poor prognosis and constitute a major challenge in offering effective treatment strategies. By targeting molecular alterations, precision cancer medicine may be a viable option for the treatment of brain tumours. In this retrospective analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghizadeh, H., Müllauer, L., Furtner, J., Hainfellner, J. A., Marosi, C., Preusser, M., Prager, G. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934769/
https://www.ncbi.nlm.nih.gov/pubmed/31882734
http://dx.doi.org/10.1038/s41598-019-56473-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934769/
https://www.ncbi.nlm.nih.gov/pubmed/31882734
http://dx.doi.org/10.1038/s41598-019-56473-0

Ejemplares similares